Allergan Inc (NYSE:AGN)

166.12
Data as of Sep 22
 -2.09 / -1.24%
Today’s Change
88.34
Today|||52-Week Range
174.49
+49.55%
Year-to-Date
Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.
12:18am / Benzinga
QLT Unveils Positive Retreatment Study Data - Analyst Blog
Sep 15 / Zacks.com
Benzinga's M&A Chatter for Monday September 22, 2014
Sep 22 / Benzinga
Novartis Presents Positive Data on Lucentis and Jetrea - Analyst Blog
Sep 15 / Zacks.com
Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog
Sep 22 / Zacks.com
Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog
Sep 15 / Zacks.com
Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog
Sep 22 / Zacks.com
Eli Lilly's Cyramza Scores in Colorectal Cancer Study - Analyst Blog
Sep 15 / Zacks.com
Bayer to Shed MaterialScience Business, Shares Rise - Analyst Blog
Sep 19 / Zacks.com
Bill Ackman plans $2bn Pershing fund IPO in Amsterdam
Sep 15 / FT.com
Eli Lilly's Trulicity Approved by FDA for Type II Diabetes - Analyst Blog
Sep 19 / Zacks.com
Sanofi Reports Data on Multiple Sclerosis Drug Lemtrada - Analyst Blog
Sep 12 / Zacks.com
Bayer/Orion Progress with Prostate Cancer Drug ODM-201 - Analyst Blog
Sep 18 / Zacks.com
Will Allergan's Board Be Revamped to Aid Valeant Buyout? - Analyst Blog
Sep 12 / Zacks.com
Merck Enters into Licensing Agreement with Sun Pharma - Analyst Blog
Sep 18 / Zacks.com
Novo Nordisk's Saxenda Gets Positive Opinion for Obesity - Analyst Blog
Sep 12 / Zacks.com
Gilead Down on Weak Simtuzumab Data and Sovaldi News - Analyst Blog
Sep 18 / Zacks.com
AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog
Sep 12 / Zacks.com
Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog
Sep 17 / Zacks.com
Abbott Labs (ABT) to Repurchase Shares for $3B - Analyst Blog
Sep 12 / Zacks.com
Novo Nordisk's Tresiba Effective in Children & Adolescents - Analyst Blog
Sep 17 / Zacks.com
Eli Lilly/Boehringer's Insulin Biosimilar Gains EU Approval - Analyst Blog
Sep 11 / Zacks.com
Abbott Labs (ABT) to Initiate New Trial on Absorb - Analyst Blog
Sep 17 / Zacks.com
Novartis Presents Data on Multiple Sclerosis Drug Gilenya - Analyst Blog
Sep 11 / Zacks.com
Endo Looking to Acquire Auxilium Pharmaceuticals for $2.2B - Analyst Blog
Sep 17 / Zacks.com
NPS Pharmaceuticals (NPSP) Shoots Up Ahead of FDA Panel - Analyst Blog
Sep 11 / Zacks.com
Why Salix Pharmaceuticals (SLXP) Stock Is Higher Today
Sep 17 / TheStreet.com
Is This the Right Time to Buy Gilead Sciences (GILD) Stock? - Analyst Blog
Sep 11 / Zacks.com
Roche Starts Trials on Lampalizumab for Geographic Atrophy - Analyst Blog
Sep 16 / Zacks.com
Peregrine Pharmaceuticals' Q1 Loss Wider than Expected - Analyst Blog
Sep 10 / Zacks.com
AstraZeneca and Eli Lilly Collaborate for Alzheimer's Drug - Analyst Blog
Sep 16 / Zacks.com
AstraZeneca Presents Unfavorable Benralizumab Study Data - Analyst Blog
Sep 09 / Zacks.com
Gilead (GILD) Slips on Generic Sovaldi Licensing Deals - Analyst Blog
Sep 16 / Zacks.com
Glaxo (GSK) Updates on Asthma Candidate Mepolizumab - Analyst Blog
Sep 09 / Zacks.com
Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data - Analyst Blog
Sep 16 / Zacks.com
Alexion's Asfotase Alfa Gets Japanese Orphan Drug Status - Analyst Blog
Sep 09 / Zacks.com
Why It's Time for Allergan Shareholders to Take Some Profits
Sep 16 / TheStreet.com
Roche's (RHHBY) RoActemra Gets EU Approval for Early RA - Analyst Blog
Sep 09 / Zacks.com
Frontrunning: September 16
Sep 16 / Investing Channel
Hospira Down on Legal Blow; Court Allows Generic Precedex - Analyst Blog
Sep 09 / Zacks.com
NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote - Analyst Blog
Sep 15 / Zacks.com
Bayer Presents Positive Long-Term Results on Adempas - Analyst Blog
Sep 09 / Zacks.com
Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog
Sep 15 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.